Subsequently, ESCC cells were treated with GW4869, a drug that obstructs exosome biogenesis by inhibiting neutral sphingomyelinase 2 (nSMase2) and reduces the miRNA content in exosomes [30], resulting in the inhibition of exosome formation. The gene discussed is SMPD3; the disease is esophageal squamous cell carcinoma.